Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Genitourinary Radiology: Page 60
Automatic segmentation technique shows promise for CT urograms
By
Erik L. Ridley
Tuesday, November 30 | 11:20 a.m.-11:30 a.m. | SSG13-06 | Room S403AIn this paper, researchers from the University of Michigan in Ann Arbor will share details on their automatic bladder lesion segmentation technique for CT urograms.
November 10, 2010
PSA screening, aspirin may reduce prostate cancer deaths
By
Cynthia E. Keen
Screening men who have been treated for prostate cancer based on prostate-specific antigen (PSA) levels can lower deaths by reducing the risk of metastasis within 10 years of treatment, according to a study to be presented at the upcoming American Society for Radiation Oncology meeting in San Diego.
October 25, 2010
Radiation boosts hormone therapy for prostate cancer patients
By
Cynthia E. Keen
High-risk prostate cancer patients who have radiation added to their regimen of androgen deprivation therapy have an improved chance of survival compared with patients who only get hormone therapy, according to a study to be presented at next week's American Society for Radiation Oncology meeting in San Diego.
October 24, 2010
Low-risk prostate cancer patients choose surveillance in U.K.
By
Cynthia E. Keen
Thousands of men in the U.K. diagnosed with low-risk localized prostate cancer are delaying aggressive treatment, according to a new study in the October issue of
BJU International
. Instead, they are opting for active surveillance that includes monitoring and testing of prostate-specific antigen levels.
October 20, 2010
Patients with incurable cancer keep getting screened
By
Kate Madden Yee
Patients with a diagnosis of advanced cancer continue to undergo common cancer screening tests that are unlikely to be beneficial, according to a study published October 12 in the
Journal of the American Medical Association
.
October 11, 2010
Calypso nets FDA OK on gating feature
By
AuntMinnie.com staff writers
Calypso Medical Technologies has received 510(k) clearance from the U.S. Food and Drug Administration to market a new Dynamic Edge gating technology for its Calypso system.
October 11, 2010
Nucletron signs license agreements
By
AuntMinnie.com staff writers
Radiation oncology firm Nucletron has signed license agreements with MedCom and Pi Medical for Oncentra Seeds, the next-generation seeds treatment planning module of Oncentra Prostate.
September 27, 2010
Use of CT grows in children with urolithiasis
By
Cynthia E. Keen
Children admitted to U.S. pediatric hospitals with symptoms of urolithiasis are more likely to have a CT scan ordered than an ultrasound exam, even though the latter is the recommended initial procedure, according an article in the October issue of the
Journal of Urology
.
September 14, 2010
FDA updates warning labels on gadolinium contrast
By
AuntMinnie.com staff writers
The U.S. Food and Drug Administration today announced that it is updating the warning labels required on three gadolinium-based MRI contrast agents sold in the U.S. due to the risk of nephrogenic systemic fibrosis.
September 8, 2010
InSightec treats prostate cancer patients
By
AuntMinnie.com staff writers
The ExAblate MR-guided focused ultrasound system from InSightec is being used for the first time for the treatment of prostate cancer patients.
August 30, 2010
MR spectroscopy with MRI detects prostate cancer recurrence
By
Wayne Forrest
Combining MR spectroscopy with T2-weighted MR imaging "significantly improves" the diagnostic accuracy of endorectal MRI to detect locally recurrent prostate cancer after external-beam radiation therapy, according to a study in the August issue of
Radiology
.
August 3, 2010
Active surveillance advised for elderly kidney cancer patients
By
Cynthia E. Keen
The best treatment for patients older than 75 who are diagnosed with localized renal cell carcinoma may be active surveillance, according to urologists at the Cleveland Clinic, whose recommendations were reported in the July 1 issue of
Cancer
.
July 8, 2010
Previous Page
Page 60 of 96
Next Page